Summary
The weight loss drug Wegovy, made by Novo Nordisk, is now available as a pill in the United States. It was approved by the FDA and aims to make it easier for people to access and afford weight loss treatment. The pill uses the same active ingredient as its injectable version and costs start at $149 per month for those paying directly.
Key Facts
- Wegovy is a weight loss drug that has now been released in pill form, approved by the FDA.
- The pill is the first oral GLP-1 receptor agonist approved for weight loss.
- It became available in U.S. pharmacies beginning Monday, following its FDA approval.
- The pill's active ingredient is semaglutide, the same as in the injectable Wegovy.
- Prices for the pill start at $149 per month for the lowest dose for those without insurance.
- Insurance may reduce the cost to as low as $25 per month under Novo Nordisk's savings program.
- The pill has shown an average weight loss of 14% in patients over 64 weeks in trials.
- Common side effects include nausea, diarrhea, and vomiting, similar to the injectable form.
- The pill isn't recommended for people under 18 or those with certain thyroid cancers.
